“…For examples, (R)-BPA is a component of astins A-C, antitumor cyclopentapeptides, isolated from the roots of a medicinal plant Aster tataricus (Morita et al 1995); (S)-BPA can be used to synthesis of pyloricidin A-D, novel anti-Helicobacter pylori antibiotics (Nagano et al 2001). Methods for producing enantiomerically pure BPA include homologation of enantiomerically pure a-amino acids (Podlech 2005), asymmetric synthesis by application of chiral sulfoxides (Sivakumar et al 2001), and enantiomeric-specific hydrolysis of corresponding racemic substances using biocatalysts, such as lipase (Faulconbridge et al 2000), a-chymotrypsin (Cohen and Weinstein 1964), penicillin G acylase (Soloshonok et al 1995) and aminoacylase (Groeger et al 2004). However, from the viewpoint of industrial application and environmental protection, the production of enantiomerically pure BPA is still a challenging project.…”